Far-infrared Ray-mediated Antioxidant Potentials are Important for Attenuating Psychotoxic Disorders

Curr Neuropharmacol. 2019;17(10):990-1002. doi: 10.2174/1570159X17666190228114318.

Abstract

Far-infrared ray (FIR) is an electromagnetic wave that produces various health benefits against pathophysiological conditions, such as diabetes mellitus, renocardiovascular disorders, stress, and depression etc. However, the therapeutic application on the FIR-mediated protective potentials remains to be further extended. To achieve better understanding on FIR-mediated therapeutic potentials, we summarized additional findings in the present study that exposure to FIR ameliorates stressful condition, memory impairments, drug dependence, and mitochondrial dysfunction in the central nervous system. In this review, we underlined that FIR requires modulations of janus kinase 2 / signal transducer and activator of transcription 3 (JAK2/STAT3), nuclear factor E2- related factor 2 (Nrf-2), muscarinic M1 acetylcholine receptor (M1 mAChR), dopamine D1 receptor, protein kinase C δ gene, and glutathione peroxidase-1 gene for exerting the protective potentials in response to neuropsychotoxic conditions.

Keywords: Far-infrared ray; JAK2/STAT3; M1 mAChR; dopamine D1 receptor; glutathione peroxidase-1; neuropsychotoxic conditions; nuclear factor E2-related factor 2; protein kinase C δ gene..

Publication types

  • Review

MeSH terms

  • Animals
  • Antioxidants / therapeutic use*
  • Humans
  • Infrared Rays / therapeutic use*
  • Janus Kinase 2 / metabolism
  • NF-E2-Related Factor 2 / metabolism
  • Nervous System Diseases / radiotherapy*
  • Receptor, Muscarinic M1 / metabolism
  • Receptors, Dopamine D1 / metabolism
  • Signal Transduction / physiology

Substances

  • Antioxidants
  • NF-E2-Related Factor 2
  • Receptor, Muscarinic M1
  • Receptors, Dopamine D1
  • Janus Kinase 2